中国肝胆肿瘤创新联盟在沪成立

Core Viewpoint - The establishment of the China Liver and Biliary Tumor Innovation Alliance marks a significant step towards a systematic and ecological collaborative development in the prevention and treatment of liver and biliary tumors in China [1][2]. Group 1: Alliance Objectives and Structure - The alliance aims to create a national, open, collaborative, and shared innovation platform involving twenty renowned medical institutions [1]. - Key transformations sought by the alliance include moving from "single discipline treatment" to "holistic management," upgrading from "project cooperation" to "platform co-creation," and evolving from "technology leadership" to "system leadership" [1]. Group 2: Data Infrastructure and Innovation - The alliance's mission is to empower the industry through a unified data infrastructure, establishing a national-level precision big data platform for liver and biliary tumors [2]. - The platform will standardize and integrate diverse medical data, including imaging, pathology, genomics, clinical treatment, and follow-up [2]. - The establishment of the big data platform is expected to provide a solid foundation for innovation in the field of liver and biliary tumor diagnosis and treatment [2]. Group 3: Research and Talent Development - The alliance will initiate and lead nationwide multi-center clinical research to address key scientific challenges in the liver and biliary tumor field [3]. - A systematic talent training mechanism will be established to enhance the professional capabilities of physicians, particularly at the grassroots level [3].